These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19242067)

  • 1. Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis.
    Ortiz GG; Macías-Islas MA; Pacheco-Moisés FP; Cruz-Ramos JA; Sustersik S; Barba EA; Aguayo A
    Dis Markers; 2009; 26(1):35-9. PubMed ID: 19242067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oxidative stress and haematological parameters in relapsing-remitting multiple sclerosis in Kurdish population.
    Rasoul AA; Khudhur ZO; Hamad MS; Ismaeal YS; Smail SW; Rasul MF; Mohammad KA; Bapir AA; Omar SA; Qadir MK; Rajab MF; Salihi A; Kaleem M; Rizwan MA; Qureshi AS; Iqbal ZM; Qudratullah
    Mult Scler Relat Disord; 2021 Nov; 56():103228. PubMed ID: 34492630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
    Yuceyar N; Taşkiran D; Sağduyu A
    Clin Neurol Neurosurg; 2001 Dec; 103(4):206-11. PubMed ID: 11714562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis.
    Sanoobar M; Eghtesadi S; Azimi A; Khalili M; Jazayeri S; Reza Gohari M
    Int J Neurosci; 2013 Nov; 123(11):776-82. PubMed ID: 23659338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of lithium serum level in multiple sclerosis patients: A neuroprotective element.
    Karimi A; Bahrampour K; Momeni Moghaddam MA; Asadikaram G; Ebrahimi G; Torkzadeh-Mahani M; Esmaeili Tarzi M; Nematollahi MH
    Mult Scler Relat Disord; 2017 Oct; 17():244-248. PubMed ID: 29055468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: a randomized controlled clinical trial.
    Khalili M; Eghtesadi S; Mirshafiey A; Eskandari G; Sanoobar M; Sahraian MA; Motevalian A; Norouzi A; Moftakhar S; Azimi A
    Nutr Neurosci; 2014 Jan; 17(1):16-20. PubMed ID: 23485514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum arsenic and its effects on antioxidant alterations in relapsing-remitting multiple sclerosis patients.
    Juybari KB; Ebrahimi G; Momeni Moghaddam MA; Asadikaram G; Torkzadeh-Mahani M; Akbari M; Mirzamohammadi S; Karimi A; Nematollahi MH
    Mult Scler Relat Disord; 2018 Jan; 19():79-84. PubMed ID: 29156301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
    Oliveira SR; Kallaur AP; Reiche EMV; Kaimen-Maciel DR; Panis C; Lozovoy MAB; Morimoto HK; Maes M; Dichi I; Simão ANC
    Mol Neurobiol; 2017 May; 54(4):2961-2968. PubMed ID: 27026183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral oxidative stress in relapsing-remitting multiple sclerosis.
    Tasset I; Agüera E; Sánchez-López F; Feijóo M; Giraldo AI; Cruz AH; Gascón F; Túnez I
    Clin Biochem; 2012 Apr; 45(6):440-4. PubMed ID: 22330938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum uric acid level in patients with relapsing-remitting multiple sclerosis.
    Ashtari F; Bahar M; Aghaei M; Zahed A
    J Clin Neurosci; 2013 May; 20(5):676-8. PubMed ID: 23528410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: relationship to oxidative stress.
    Bahamonde C; Conde C; Agüera E; Lillo R; Luque E; Gascón F; Feijóo M; Cruz AH; Sánchez-López F; Túnez I
    Eur J Pharmacol; 2014 May; 730():26-30. PubMed ID: 24582759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA 26a Expression in Peripheral Blood Mononuclear Cells and Correlation with Serum Interleukin-17 in Relapsing-Remitting Multiple Sclerosis Patients.
    Mahmoud FM; ElSheshtawy NM; Zaki WK; Zamzam DM; Fahim NM
    Egypt J Immunol; 2017 Jun; 24(2):71-82. PubMed ID: 29528581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristics.
    Ghonimi NAM; Elsharkawi KA; Khyal DSM; Abdelghani AA
    Mult Scler Relat Disord; 2021 Jun; 51():102941. PubMed ID: 33895606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis.
    Sánchez-López AL; Ortiz GG; Pacheco-Moises FP; Mireles-Ramírez MA; Bitzer-Quintero OK; Delgado-Lara DLC; Ramírez-Jirano LJ; Velázquez-Brizuela IE
    Arch Med Res; 2018 Aug; 49(6):391-398. PubMed ID: 30595364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis.
    Aydin O; Ellidag HY; Eren E; Kurtulus F; Yaman A; Yılmaz N
    Biochem Med (Zagreb); 2014; 24(3):383-9. PubMed ID: 25351357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C/EBP homologous protein investigation in the serum and cerebro-spinal fluid of relapsing-remitting multiple sclerosis patients.
    Karami M; Aleagha MSE; Seidkhani-Nahal A; Bakhtiyari S; Noori-Zadeh A; Harirchian MH; Siroos B; Balood M; Khosravi A
    J Clin Neurosci; 2019 Jan; 59():51-54. PubMed ID: 30446370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
    Tasset I; Bahamonde C; Agüera E; Conde C; Cruz AH; Pérez-Herrera A; Gascón F; Giraldo AI; Ruiz MC; Lillo R; Sánchez-López F; Túnez I
    Pharmacol Rep; 2013; 65(3):624-31. PubMed ID: 23950585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma.
    Rasheed MH; Beevi SS; Geetha A
    Oral Oncol; 2007 Apr; 43(4):333-8. PubMed ID: 16857409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malondialdehyde and nitric oxide levels in the plasma of patients with advanced laryngeal cancer.
    Taysi S; Uslu C; Akcay F; Sutbeyaz MY
    Surg Today; 2003; 33(9):651-4. PubMed ID: 12928839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma malondialdehyde and nitric oxide levels in age related macular degeneration.
    Totan Y; Cekiç O; Borazan M; Uz E; Sögüt S; Akyol O
    Br J Ophthalmol; 2001 Dec; 85(12):1426-8. PubMed ID: 11734513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.